2019 Chemotherapy Compounding 
European Pharmaceutical Review
OCTOBER 19, 2023
With alpha particles, you must be very careful how the drug is made to ensure that the compound remains stable between manufacturing and use. How do you perceive radiopharmaceuticals complementing existing cancer treatments, such as chemotherapy and immunotherapy? What do you envision the future of radiopharmaceuticals to be like?
The Checkup by Singlecare
MARCH 23, 2023
Understanding the difference between CBD vs. marijuana Cannabinoids are compounds found in the cannabis plant, Cannabis sativa. A 2019 study used hemp-derived CBD in patients taking opioids to manage their chronic pain. They are prescribed to increase appetite in patients receiving chemotherapy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Blog: Ask a Student Pharmacist
JUNE 21, 2023
Jiashu Xie, PhD eomizowh Wed, 06/21/2023 - 10:11 Expand all + Biography Research Summary Current research in the Pharmacokinetics (PK) lab has focused on profiling the in vitro ADME (absorption, distribution, metabolism, and excretion) and in vivo PK properties of lead compounds from medicinal chemistry efforts. 2019; 62(9): 4669-4682.
The Thyroid Pharmacist
SEPTEMBER 20, 2024
Tenapanor : Tenapanor was approved by the FDA in September of 2019 for IBS-C. Chemotherapy agents: Chemotherapy agents can lead to constipation in a variety of ways such as slowing the movements of the intestinal tract or creating inflammation that disrupts digestive function. April 24, 2019. Published 2019 Feb 12.
The Thyroid Pharmacist
NOVEMBER 4, 2022
While the human body (via the liver and kidneys) can produce up to 4 g/day of inositol, it has been found that the overly processed, high glucose (and low fiber) Western diets that many people follow, only provide about 1 g/day of the compound. (7). Published 2019 Oct 11. Recommended Dosage and Precautions. Minerva Ginecol. 2019.01172.
European Pharmaceutical Review
JULY 5, 2022
The availability of oral chemotherapy treatments would provide stomach cancer patients with the option of more efficacious drugs with improved tolerability in a more convenient dosage format” The poor clinical outcomes of stomach cancer make it a key target for drug development. Benefits of daily oral chemotherapy over IV.
pharmaphorum
APRIL 20, 2021
One of the filings is to convert the ADC’s current conditional approval as a later-line therapy for urothelial cancer in patients previously treated with PD-1/L1 checkpoint inhibitors and platinum-based chemotherapy into a full approval. Both have been granted an FDA priority review with an action date of 17 August.
Expert insights. Personalized for you.
105 
Let's personalize your content